Thérapie, 58 5 (2003) 425-430

Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Impacts de la nouvelle réglementation du flunitrazépam sur la consommation d'hypnotiques

Caroline Victorri-Vigneau, Gilles Basset, Michel Bourin, Pascale Jolliet

Thérapie, 58 5 (2003) 425-430

Publié en ligne : 2007-03-01

DOI: https://doi.org/10.2515/therapie:2003069

PDF (202.3 KB)

Citations de cet article :

Inputs of pharmacoepidemiology in addictovigilance: How do they fit together?

Thomas Soeiro, Amélie Daveluy, Caroline Victorri-Vigneau, Maryse Lapeyre-Mestre and Joëlle Micallef
Therapies 80 (2) 205 (2025)
https://doi.org/10.1016/j.therap.2024.10.058

Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study

Aurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, Morgane Rousselet, Marie Gérardin, Emilie Jouanjus, Frédéric Libert, Anne-Sylvie Caous, Samira Djezzar, Alexandra Boucher, Amélie Daveluy, Céline Eiden, Bernard Fauconneau, Christine Fournier-Choma, Valérie Gibaja, Clémence Lacroix, Maryse Lapeyre-Mestre, Reynald Le Boisselier, Bruno Revol, Marylène Guerlais and Caroline Victorri-Vigneau
International Journal of Mental Health and Addiction 22 (6) 3733 (2024)
https://doi.org/10.1007/s11469-023-01078-y

Flunitrazepam alters the toxicokinetics of chlorpromazine enhancing its toxicity

Kota Nakajima, Asuka Kaizaki-Mitsumoto and Satoshi Numazawa
Fundamental Toxicological Sciences 10 (8) 315 (2023)
https://doi.org/10.2131/fts.10.315

Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study

Marion Istvan, Pascal Caillet, Morgane Rousselet, Marylène Guerlais, Edouard‐Jules Laforgue, Marie Gérardin, Pascale Jolliet, Fanny Feuillet and Caroline Victorri‐Vigneau
British Journal of Clinical Pharmacology 87 (8) 3310 (2021)
https://doi.org/10.1111/bcp.14753

The Palgrave Handbook of American Mental Health Policy

Keith Humphreys and Harold A. Pollack
The Palgrave Handbook of American Mental Health Policy 259 (2020)
https://doi.org/10.1007/978-3-030-11908-9_10

Impact de la nouvelle réglementation du zolpidem – enquête dans la circonscription départementale du Rhône

E. Chambost and M. Chappuy
Le Pharmacien Hospitalier et Clinicien 53 (4) 288 (2018)
https://doi.org/10.1016/j.phclin.2018.04.003

Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion

Emilie Jouanjus, Grégory Guernec and Maryse Lapeyre‐Mestre
Fundamental & Clinical Pharmacology 32 (3) 306 (2018)
https://doi.org/10.1111/fcp.12356

Neuropathology of Drug Addictions and Substance Misuse

Joëlle Micallef, Elisabeth Frauger and Maryse Lapeyre-Mestre
Neuropathology of Drug Addictions and Substance Misuse 1101 (2016)
https://doi.org/10.1016/B978-0-12-800212-4.00102-3

Patterns of Methylphenidate Use and Assessment of its Abuse and Diversion in Two French Administrative Areas Using a Proxy of Deviant Behaviour Determined from a Reimbursement Database

Elisabeth Frauger, Vanessa Pauly, François Natali, et al.
CNS Drugs 25 (5) 415 (2011)
https://doi.org/10.2165/11587640-000000000-00000

Epidemiological Characterization of Drug Overconsumption: The Example of Antidepressants

Caroline Victorri-Vigneau, Véronique Sébille, Marie Gérardin, et al.
Journal of Addictive Diseases 30 (4) 342 (2011)
https://doi.org/10.1080/10550887.2011.610712

Pharmacoepidemiological research using French reimbursement databases: yes we can!

Karin Martin‐Latry and Bernard Bégaud
Pharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
81 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.006

Création et validation d’un outil de détection de la fraude par falsification d’ordonnance à partir des bases de données de l’Assurance Maladie

Caroline Victorri-Vigneau, Katia Larour, Dominique Simon, Jacques Pivette and Pascale Jolliet
Thérapie 64 (1) 27 (2009)
https://doi.org/10.2515/therapie/2009004

v (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.002.0004

261 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.005.01

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
47 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.004

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
251 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.016

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
97 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.007

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
123 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.009

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
139 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.010

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
13 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.002

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
27 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.003

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
105 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.008

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
235 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.015

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
221 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.014

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
63 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.005

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
163 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.011

xi (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.002.0007

vii (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.002.0005

iv (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.002.0003

Thomas F. Babor, Jonathan P. Caulkins, Griffith Edwards, Benedikt Fischer, David R. Foxcroft, Keith Humphreys, Isidore S. Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
(2009)
https://doi.org/10.1093/acprof:oso/9780199557127.001.0001

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
179 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.012

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
3 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.001

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow and John Strang
203 (2009)
https://doi.org/10.1093/acprof:oso/9780199557127.003.013

Premières journées nationales de pharmacodépendance (CEIP). Place de la pharmacodépendance dans l’évaluation du médicament

Joëlle Micaleff, Pascale Jolliet, Caroline Victorri-Vigneau, et al.
Thérapie 63 (1) 55 (2008)
https://doi.org/10.2515/therapie:2008014

Abus et dépendances aux produits psychoactifs : étude de consommations à travers l’enquête OPPIDUM 2004 du réseau des CEIP

Hugues Modelon, Elisabeth Frauger, Delphine Laurenceau, et al.
Therapies 62 (4) 337 (2007)
https://doi.org/10.2515/therapie:2007061

Réactivité et communication des décisions de pharmacovigilance des autorités de santé vers les professionnels de santé : exemples du pergolide et du célécoxib

Caroline Victorri-Vigneau, Marie Marais, Gwenaëlle Veyrac, et al.
Thérapie 62 (6) 513 (2007)
https://doi.org/10.2515/therapie:2007064

Étude des reports de prescription : objectifs, méthodes et limites

Vincent Pradel, Joëlle Micallef and Olivier Blin
Therapies 62 (1) 31 (2007)
https://doi.org/10.2515/therapie:2007011

Score de gravité de la pharmacodépendance : proposition d’une grille d’évaluation des notifications des CEIP

Caroline Victorri-Vigneau and Pascale Jolliet
Therapies 61 (6) 517 (2006)
https://doi.org/10.2515/therapie:2006089

How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France

C. Victorri-Vigneau, G. Basset and P. Jolliet
European Journal of Clinical Pharmacology 62 (4) 311 (2006)
https://doi.org/10.1007/s00228-006-0099-x

Utilisation des bases de données de l’Assurance Maladie par les Centres d’Evaluation et d’Information sur la Pharmacodépendance : exemples, intérêts et perspectives

Joëlle Micallef, Vincent Pradel, Xavier Thirion, Pascale Jolliet and Maryse Lapeyre-Mestre
Therapies 59 (6) 581 (2004)
https://doi.org/10.2515/therapie:2004100